← back to search

Yang Hu

Cornell University · US
Area of research
Molecular Biology · Immunology
Research interest
Research interests include Immune cells in cancer, Wnt/β-catenin signaling in development and cancer, Cancer-related gene regulation, and Glioma Diagnosis and Treatment.
h-index
17
citations
1,454
works
66
NIH funding
primary concept
email

Recent publications

Rewiring Endothelial Sphingolipid Metabolism to Favor S1P Over Ceramide Protects From Coronary Atherosclerosis
Circulation Research 2024cited by 24position: middledoi
Single-cell RNA sequencing reveals immunosuppressive myeloid cell diversity during malignant progression in a murine model of glioma
Cell Reports 2023cited by 65position: middledoi
Tumor-intrinsic IRE1α signaling controls protective immunity in lung cancer
Nature Communications 2023cited by 34position: middledoi
SPRY4-dependent ERK negative feedback demarcates functional adult stem cells in the male mouse germline
Biology of Reproduction 2023cited by 9position: middledoi
Tumor-Infiltrating Myeloid Cells Confer <i>De Novo</i> Resistance to PD-L1 Blockade through EMT–Stromal and Tgfβ-Dependent Mechanisms
Molecular Cancer Therapeutics 2022cited by 8position: middledoi
The aging skin microenvironment dictates stem cell behavior
Proceedings of the National Academy of Sciences 2020cited by 186position: middledoi
Tumor Microenvironment Is Critical for the Maintenance of Cellular States Found in Primary Glioblastomas
Cancer Discovery 2020cited by 173position: middledoi
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
Nature Communications 2020cited by 132position: middledoi
Single-cell profiling reveals an endothelium-mediated immunomodulatory pathway in the eye choroid
The Journal of Experimental Medicine 2020cited by 100position: middledoi
Lineage Reversion Drives WNT Independence in Intestinal Cancer
Cancer Discovery 2020cited by 81position: middledoi
Epithelial plasticity can generate multi-lineage phenotypes in human and murine bladder cancers
Nature Communications 2020cited by 68position: middledoi
Dynamic transcriptome profiles within spermatogonial and spermatocyte populations during postnatal testis maturation revealed by single-cell sequencing
PLoS Genetics 2019cited by 121position: middledoi
Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations
Journal of Molecular Diagnostics 2017cited by 76position: middledoi
&lt;i&gt;luxS&lt;/i&gt;/AI-2 Quorum Sensing Is Involved in Antimicrobial Susceptibility in &lt;i&gt;Streptococcus agalactiae&lt;/i&gt;
Fish Pathology 2015cited by 6position: middledoi

Grants

CAREER: Rethinking the Architectures and Systems for Autonomous Driving Infrastructure
NSF1943490$187,4312020–2022PIRePORTER

Frequent collaborators

Olivier Elemento · Cornell University10 papers (2019–2024)David J. Mulholland · Icahn School of Medicine at Mount Sinai2 papers (2020–2022)Akanksha Verma · Sanjay Gandhi Post Graduate Institute of Medical Sciences2 papers (2020–2023)Jorge Daza · Icahn School of Medicine at Mount Sinai2 papers (2020–2022)John P. Sfakianos · Mount Sinai Medical Center2 papers (2020–2022)Matthew D. Galsky · Rutgers New Jersey Medical School2 papers (2020–2022)Bishoy M. Faltas · Cornell University2 papers (2020–2022)Ekta Khurana · Cornell University1 papers (2020–2020)Howard A. Fine · Cornell University1 papers (2020–2020)Theodore H. Schwartz · Mount Sinai Hospital1 papers (2020–2020)Nuria Mencia-Trinchant · NewYork–Presbyterian Hospital1 papers (2017–2017)Julie K. Freed · Medical College of Wisconsin1 papers (2024–2024)Paula E. Cohen · Cornell University1 papers (2019–2019)Pauline Marangoni · University of California, San Francisco1 papers (2023–2023)Amy C. Gross · The Ohio State University1 papers (2023–2023)Juan R. Cubillos‐Ruiz · Cornell University1 papers (2023–2023)Bas J. Wouters · Erasmus MC1 papers (2017–2017)Mónica L. Guzmán · NewYork–Presbyterian Hospital1 papers (2017–2017)Elaine R. Mardis · James S. McDonnell Foundation1 papers (2023–2023)Nina Bhardwaj · Institut de Recherche Vaccinale1 papers (2022–2022)